Skip to main content

Animations

MJFF Publications

5961 - 5970 of 8801 Results
Title
Year
  • Year
  • 2021
  • 2019
  • 2016
  • 2019
  • 2021
  • 2022
  • 2023
  • 2017
  • 2023
  • 2025
  • Summary Details
    OPEN
    Title: DeepSleep convolutional neural network allows accurate and fast detection of sleep arousal
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-020-01542-8
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181518
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26754
    Citation Count: 140
  • Summary Details
    OPEN
    Title: Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.016
    Citation Count: 46
  • Summary Details
    OPEN
    Title: The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-79726-9
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Interaction of Mitochondrial Polygenic Score and Lifestyle Factors in LRRK2 p.Gly2019Ser Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29563
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0456-2
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13506
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41556-025-01623-y
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.